Work underway to implement new guidance for diabetes management in Sussex

The National Institute for Health and Care Excellence (NICE) has updated its guidance in March 2022,  people living with diabetes access to new technology to help manage their condition.

Recommendations for the expansion of use of real time continuous glucose monitoring (rtCGM) have been made for both adults and children and young people with Type 1 diabetes

Alongside this, intermittently scanned glucose monitoring (isCGM) devices – also known as flash monitoring – have been recommended for patients with type 1 diabetes and a defined group of adults with type 2 diabetes on multiple daily injections of insulin.

We are working closely with diabetes specialist colleagues and other local stakeholders to review and understand how we can look to implement the new guidance in Sussex.

We aim to maximise benefits, prioritise diabetes patients with greatest clinical need and allow all patients access to the best possible treatment for their clinical circumstances within the resources of our health system.

We appreciate that there is a lot of interest in this – please bear with us while we complete this work. We will share an update as soon as possible.